Celiac disease in Iran: a systematic review and meta-analysis
Introduction: Celiac disease (CD) is a chronic autoimmune-mediated disorder with both intestinal and systemic manifestations. The aim of this study was to determine the prevalence of celiac disease in Iran. Methods: We conducted a systematic search on Embase, Pub Med, Web of Science, Google Schola...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Electronic Physician
2017-03-01
|
Series: | Electronic Physician |
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407219/ |
id |
doaj-ff8e078a268648c5b78e7ee6f8dec906 |
---|---|
record_format |
Article |
spelling |
doaj-ff8e078a268648c5b78e7ee6f8dec9062020-11-24T22:06:43ZengElectronic PhysicianElectronic Physician2008-58422008-58422017-03-01933883389510.19082/3883Celiac disease in Iran: a systematic review and meta-analysisRoghayeh MohammadibakhshRahim Sohrabi,Morteza Salemi,Masood Taheri MirghaedMasoud BehzadifarIntroduction: Celiac disease (CD) is a chronic autoimmune-mediated disorder with both intestinal and systemic manifestations. The aim of this study was to determine the prevalence of celiac disease in Iran. Methods: We conducted a systematic search on Embase, Pub Med, Web of Science, Google Scholar, MagIran, Scientific Information database (SID) and Iranmedex from 2003 through to November 2015. The Der-Simonian/ Laird’s (DL), with a 95% confidence interval employed to estimate the overall pooled prevalence. Heterogeneity was investigated by using subgroup analysis based on sample size and time of study. Results: Sixty-three studies with 36,833 participants met inclusion criteria for analysis. The overall prevalence of celiac disease in 63 studies that had used serological tests for the diagnosis was observed as 3% (95% CI: 0.03- 0.03) and the overall prevalence of celiac disease in studies that had used biopsy method for diagnosis was observed as 2% (95% CI: 0.01- 0.02). Conclusion: The prevalence of celiac disease in Iran was similar or even higher than world-wide reportedhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407219/PrevalenceMeta-analysisCeliac diseaseIran |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Roghayeh Mohammadibakhsh Rahim Sohrabi, Morteza Salemi, Masood Taheri Mirghaed Masoud Behzadifar |
spellingShingle |
Roghayeh Mohammadibakhsh Rahim Sohrabi, Morteza Salemi, Masood Taheri Mirghaed Masoud Behzadifar Celiac disease in Iran: a systematic review and meta-analysis Electronic Physician Prevalence Meta-analysis Celiac disease Iran |
author_facet |
Roghayeh Mohammadibakhsh Rahim Sohrabi, Morteza Salemi, Masood Taheri Mirghaed Masoud Behzadifar |
author_sort |
Roghayeh Mohammadibakhsh |
title |
Celiac disease in Iran: a systematic review and meta-analysis |
title_short |
Celiac disease in Iran: a systematic review and meta-analysis |
title_full |
Celiac disease in Iran: a systematic review and meta-analysis |
title_fullStr |
Celiac disease in Iran: a systematic review and meta-analysis |
title_full_unstemmed |
Celiac disease in Iran: a systematic review and meta-analysis |
title_sort |
celiac disease in iran: a systematic review and meta-analysis |
publisher |
Electronic Physician |
series |
Electronic Physician |
issn |
2008-5842 2008-5842 |
publishDate |
2017-03-01 |
description |
Introduction: Celiac disease (CD) is a chronic autoimmune-mediated disorder with both intestinal and systemic
manifestations. The aim of this study was to determine the prevalence of celiac disease in Iran.
Methods: We conducted a systematic search on Embase, Pub Med, Web of Science, Google Scholar, MagIran,
Scientific Information database (SID) and Iranmedex from 2003 through to November 2015. The Der-Simonian/
Laird’s (DL), with a 95% confidence interval employed to estimate the overall pooled prevalence. Heterogeneity
was investigated by using subgroup analysis based on sample size and time of study.
Results: Sixty-three studies with 36,833 participants met inclusion criteria for analysis. The overall prevalence of
celiac disease in 63 studies that had used serological tests for the diagnosis was observed as 3% (95% CI: 0.03- 0.03) and the overall prevalence of celiac disease in studies that had used biopsy method for diagnosis was
observed as 2% (95% CI: 0.01- 0.02).
Conclusion: The prevalence of celiac disease in Iran was similar or even higher than world-wide reported |
topic |
Prevalence Meta-analysis Celiac disease Iran |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407219/ |
work_keys_str_mv |
AT roghayehmohammadibakhsh celiacdiseaseiniranasystematicreviewandmetaanalysis AT rahimsohrabi celiacdiseaseiniranasystematicreviewandmetaanalysis AT mortezasalemi celiacdiseaseiniranasystematicreviewandmetaanalysis AT masoodtaherimirghaed celiacdiseaseiniranasystematicreviewandmetaanalysis AT masoudbehzadifar celiacdiseaseiniranasystematicreviewandmetaanalysis |
_version_ |
1725822239795838976 |